| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.859 | 0.003 | 0.859 | DNA directed RNA polymerase inhibitor | 0.554 0.004 DBMET02135 | ||
| 0.396 | 0.004 | 0.396 | HIV-1 reverse transcriptase inhibitor | 0.251 0.007 DBMET02135 | ||
| 0.135 | 0.017 | 0.135 | Nav1.8 sodium channel blocker | 0.09 0.034 DBMET02135 | ||
| 0.163 | 0.046 | 0.163 | Sodium channel (voltage-gated) blocker | 0.134 0.069 DBMET02135 | ||
| 0.199 | 0.083 | 0.199 | Anticonvulsant | |||
| 0.233 | 0.128 | 0.233 | Ca(v)3.3 blocker | 0.208 0.175 DBMET02135 | ||
| 0.137 | 0.034 | 0.137 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.115 | 0.015 | 0.115 | TRPA1 antagonist | |||
| 0.249 | 0.214 | 0.249 | Cyclophilin D inhibitor | |||
| 0.255 | 0.227 | 0.255 | MAP kinase 1 inhibitor | |||
| 0.114 | 0.091 | 0.114 | Sodium channel blocker | |||
| 0.037 | 0.019 | 0.037 | Estrogen-related receptor alpha antagonist | 0.035 0.02 DBMET02135 | ||
| 0.039 | 0.03 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.053 | 0.045 | 0.053 | Fatty acid synthase inhibitor | |||
| 0.036 | 0.042 | 0.047 | 5 Hydroxytryptamine 1A agonist | 0.047 0.031 DBMET02135 | DBMET02135 | |
| 0.056 | 0.067 | 0.073 | Lipase inhibitor | 0.073 0.051 DBMET02135 | DBMET02135 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |